Drug Approvals
NCI NewsVarmus: "We Are Shrinking Everything"To Keep Grant Numbers Level During CutsVarmus's Remarks to the BSA, Nov. 7, 2013 from The Cancer Letter on Vimeo.
ISSUE 43 - NOV. 15, 2013PDF"Master Protocol" To Rely on Biomarkers In Testing Multiple Lung Cancer AgentsA new kind of clinical trial that will assign patients to therapy based on molecular characteristics of their disease is being launched by a coalition of government agencies, pharmaceutical companies, and a non-government organization.
In BriefLYNNE PENBERTHY was named associate director for surveillance research in NCI's Division of Cancer Control and Population Sciences.
In BriefLARRY KUN was named clinical director and executive vice president of St. Jude Children's Research Hospital.
